Celsite® Peritoneal

For loco-regional chemotherapy of peritoneal metastases and ovarian cancer

The Celsite® Peritoneal Access Port Systems are indicated for peritoneal applications and permit loco-regional chemotherapy of peritoneal metastases and ovarian cancer.

The radiopaque silicone catheter with multiple perforations ensures optimal diffusion of infused drugs and reliable patency of the catheter.
 

Special Features

• Connection is secured with the radiopaque titanium connection ring
• Radiopaque 15F silicone catheter with multiple perforations ensures optimal diffusion
• Compact port design with enlarged puncture area in relation to the port housing size
   

General Features

• Anatomic design and lower profiled nose for simplified insertion and patient comfort
• Titanium chamber for enhanced security
• High density silicone septum for reliable puncture and to ensure maximum port life
• 2 suture holes to facilitate fixation of the port
• MRI compatible, Latex, DEHP and PVC free
   

Available Implantation Technique

• Percutaneous
   

Additional Information
 

Celsite® Peritoneal is implanted at the base of the ribs and the catheter is placed at the desired location inside the abdominal cavity.